Position in ATAI
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$665,636
New position
Shares Held
188,033
first reported quarter
Ownership
0.051%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026IQ EQ FUND MANAGEMENT (IRELAND) Ltd holds $54,956,129 across 12 Biotechnology names. ATAI ranks #10 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
400,877 | $19,069,718 | |
| 2 | BEAM |
Beam Therapeutics Inc.
|
488,417 | $11,638,977 | |
| 3 | NTLA |
Intellia Therapeutics, Inc.
|
724,286 | $9,285,346 | |
| 4 | RXRX |
Recursion Pharmaceuticals, Inc.
|
2,557,403 | $7,851,227 | |
| 5 | ABSI |
Absci Corp
|
541,182 | $1,623,546 | |
| 6 | NRIX |
Nurix Therapeutics, Inc.
|
81,760 | $1,267,280 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
14,389 | $1,080,470 | |
| 8 | ARCT |
Arcturus Therapeutics Holdings Inc.
|
114,255 | $882,048 |
All Filings in ATAI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $665,636 | 188,033 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||